Looking for our Business Solutions? Click here:
CloudQuote APIs
Contact Us
Stocks
News
ETFs
Economy
Currencies
Press Releases
Terumo Corp (TRUMF)
Last Price
13.66
Change
+0.26 (1.93%)
OP
· Last Trade: Oct 9th, 7:34 PM EDT
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
benzinga.com
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via
Benzinga
· January 23, 2024
